BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 18689907)

  • 1. Clinical course and prognostic factors of clinical early IgA nephropathy.
    Shen P; He L; Huang D
    Neth J Med; 2008 Jun; 66(6):242-7. PubMed ID: 18689907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history and prognostic factors of IgA nephropathy presented with isolated microscopic hematuria in Chinese patients.
    Shen P; He L; Li Y; Wang Y; Chan M
    Nephron Clin Pract; 2007; 106(4):c157-61. PubMed ID: 17596724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological characteristics and prognostic factors of asymptomatic IgA nephropathy.
    Shen PC; He LQ; Tang Y; Wang Q; Wang W; Li J
    J Investig Med; 2010 Mar; 58(3):560-5. PubMed ID: 20215916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of low-molecular-weight proteins as prognostic markers in IgA nephropathy.
    Peters HP; van den Brand JA; Wetzels JF
    Neth J Med; 2009 Feb; 67(2):54-61. PubMed ID: 19299847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
    Komatsu H; Fujimoto S; Sato Y; Hara S; Yamada K; Morita S; Eto T
    J Nephrol; 2005; 18(6):690-5. PubMed ID: 16358226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular diseases and their risk factors in IgA nephropathy.
    Myllymäki J; Syrjänen J; Helin H; Pasternack A; Kattainen A; Mustonen J
    Nephrol Dial Transplant; 2006 Jul; 21(7):1876-82. PubMed ID: 16522659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and natural history of IgA nephropathy.
    Rychlik I; Andrassy K; Waldherr R; Zuna I; Tesar V; Jancová E; Stejskalová A; Ritz E
    Ann Med Interne (Paris); 1999 Feb; 150(2):117-26. PubMed ID: 10392260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system.
    Lee HS; Lee MS; Lee SM; Lee SY; Lee ES; Lee EY; Park SY; Han JS; Kim S; Lee JS
    Nephrol Dial Transplant; 2005 Feb; 20(2):342-8. PubMed ID: 15618239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA nephropathy in patients over 50 years of age: a multicentre, prospective study.
    Frimat L; Hestin D; Aymard B; Mayeux D; Renoult E; Kessler M
    Nephrol Dial Transplant; 1996 Jun; 11(6):1043-7. PubMed ID: 8671966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uric acid correlates with the severity of histopathological parameters in IgA nephropathy.
    Myllymäki J; Honkanen T; Syrjänen J; Helin H; Rantala I; Pasternack A; Mustonen J
    Nephrol Dial Transplant; 2005 Jan; 20(1):89-95. PubMed ID: 15572382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
    Bazzi C; Rizza V; Paparella M; Casellato D; Napodano P; Olivieri G; D'Amico G
    J Nephrol; 2009; 22(3):387-96. PubMed ID: 19557716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predicting progression of IgA nephropathies.
    Coppo R; D'Amico G
    J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological alterations in renal specimens as indicators of prognosis of IgA nephropathy.
    Okada H; Suzuki H; Konishi K; Sakaguchi H; Saruta T
    Clin Nephrol; 1992 May; 37(5):235-8. PubMed ID: 1606773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical features and prognosis of IgA nephropathy with glomerular crescents].
    Wan X; Li JG; Bai J; Huang HH; Su XY
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):336-9. PubMed ID: 17425986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Useful indicators for performing renal biopsy in adult patients with isolated microscopic haematuria.
    Shen P; He L; Jiang Y; Wang C; Chen M
    Int J Clin Pract; 2007 May; 61(5):789-94. PubMed ID: 17362478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presentation, prognosis and outcome of IgA nephropathy in Indian adults.
    Chacko B; John GT; Neelakantan N; Korula A; Balakrishnan N; Kirubakaran MG; Jacob CK
    Nephrology (Carlton); 2005 Oct; 10(5):496-503. PubMed ID: 16221102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
    Moriyama T; Nitta K; Suzuki K; Honda K; Horita S; Uchida K; Yumura W; Tanabe K; Toma H; Nihei H; Yamaguchi Y
    Clin Transplant; 2005; 19 Suppl 14():41-8. PubMed ID: 15955168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin A nephropathy in China: progress and challenges.
    Cai GY; Chen XM
    Am J Nephrol; 2009; 30(3):268-73. PubMed ID: 19521068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A candidate gene approach to genetic prognostic factors of IgA nephropathy--a result of Polymorphism REsearch to DIstinguish genetic factors Contributing To progression of IgA Nephropathy (PREDICT-IgAN).
    Yamamoto R; Nagasawa Y; Shoji T; Inoue K; Uehata T; Kaneko T; Okada T; Yamauchi A; Tsubakihara Y; Imai E; Isaka Y; Rakugi H
    Nephrol Dial Transplant; 2009 Dec; 24(12):3686-94. PubMed ID: 19420105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.